Agriculture
Swine Mycoplasma Pneumonia Live Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Nov 01, 24
- ID: 618549
- Pages: 121
- Figures: 240
- Views: 1
Swine Mycoplasma Pneumonia Live Vaccine is a vaccine used to prevent respiratory diseases caused by Mycoplasma hyopneumoniae in pigs. This vaccine is a live attenuated vaccine that helps to stimulate the pig's immune system to recognize and fight against the bacteria that causes pneumonia.
The global market for Swine Mycoplasma Pneumonia Live Vaccine was estimated to be worth US$ 214 million in 2023 and is forecast to a readjusted size of US$ 337.1 million by 2030 with a CAGR of 6.2% during the forecast period 2024-2030
North American market for Swine Mycoplasma Pneumonia Live Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Swine Mycoplasma Pneumonia Live Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Swine Mycoplasma Pneumonia Live Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Swine Mycoplasma Pneumonia Live Vaccine include Zoetis, Boehringer Ingelheim, Merck, HIPRA, Ceva Santé Animale, Harbin Pharmaceutical Group, Qilu Animal Health Products, Guangdong Winsun Bio-Pharmaceutical and Jilin HeYuan Bioengineering, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swine Mycoplasma Pneumonia Live Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Swine Mycoplasma Pneumonia Live Vaccine by region & country, by Type, and by Application.
The Swine Mycoplasma Pneumonia Live Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Mycoplasma Pneumonia Live Vaccine.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck
HIPRA
Ceva Santé Animale
Harbin Pharmaceutical Group
Qilu Animal Health Products
Guangdong Winsun Bio-Pharmaceutical
Jilin HeYuan Bioengineering
Jofunhwa Biotechnology
Segment by Type:
168 Strains
RM48 Strains
Other
Segment by Application
Piglets
Adult Pigs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Swine Mycoplasma Pneumonia Live Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Swine Mycoplasma Pneumonia Live Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Swine Mycoplasma Pneumonia Live Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Swine Mycoplasma Pneumonia Live Vaccine was estimated to be worth US$ 214 million in 2023 and is forecast to a readjusted size of US$ 337.1 million by 2030 with a CAGR of 6.2% during the forecast period 2024-2030
North American market for Swine Mycoplasma Pneumonia Live Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Swine Mycoplasma Pneumonia Live Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Swine Mycoplasma Pneumonia Live Vaccine was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Swine Mycoplasma Pneumonia Live Vaccine include Zoetis, Boehringer Ingelheim, Merck, HIPRA, Ceva Santé Animale, Harbin Pharmaceutical Group, Qilu Animal Health Products, Guangdong Winsun Bio-Pharmaceutical and Jilin HeYuan Bioengineering, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Swine Mycoplasma Pneumonia Live Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Swine Mycoplasma Pneumonia Live Vaccine by region & country, by Type, and by Application.
The Swine Mycoplasma Pneumonia Live Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Mycoplasma Pneumonia Live Vaccine.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck
HIPRA
Ceva Santé Animale
Harbin Pharmaceutical Group
Qilu Animal Health Products
Guangdong Winsun Bio-Pharmaceutical
Jilin HeYuan Bioengineering
Jofunhwa Biotechnology
Segment by Type:
168 Strains
RM48 Strains
Other
Segment by Application
Piglets
Adult Pigs
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Swine Mycoplasma Pneumonia Live Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Swine Mycoplasma Pneumonia Live Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Swine Mycoplasma Pneumonia Live Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Swine Mycoplasma Pneumonia Live Vaccine Product Introduction
1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast
1.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030)
1.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume (2019-2030)
1.2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Price (2019-2030)
1.3 Swine Mycoplasma Pneumonia Live Vaccine Market Trends & Drivers
1.3.1 Swine Mycoplasma Pneumonia Live Vaccine Industry Trends
1.3.2 Swine Mycoplasma Pneumonia Live Vaccine Market Drivers & Opportunity
1.3.3 Swine Mycoplasma Pneumonia Live Vaccine Market Challenges
1.3.4 Swine Mycoplasma Pneumonia Live Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Players Revenue Ranking (2023)
2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Company (2019-2024)
2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Players Sales Volume Ranking (2023)
2.4 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Swine Mycoplasma Pneumonia Live Vaccine
2.9 Swine Mycoplasma Pneumonia Live Vaccine Market Competitive Analysis
2.9.1 Swine Mycoplasma Pneumonia Live Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Swine Mycoplasma Pneumonia Live Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Mycoplasma Pneumonia Live Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 168 Strains
3.1.2 RM48 Strains
3.1.3 Other
3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type
3.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Type
3.3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Piglets
4.1.2 Adult Pigs
4.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application
4.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Application
4.3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region
5.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region
5.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
5.4.2 North America Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
5.5.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
5.7.2 South America Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value
6.2.1 Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.3.2 United States Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.4.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.5.2 China Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.6.2 Japan Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.7.2 South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.9.2 India Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Company Information
7.1.2 Zoetis Introduction and Business Overview
7.1.3 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.1.5 Zoetis Recent Development
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Information
7.2.2 Boehringer Ingelheim Introduction and Business Overview
7.2.3 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.2.5 Boehringer Ingelheim Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Introduction and Business Overview
7.3.3 Merck Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.3.5 Merck Recent Development
7.4 HIPRA
7.4.1 HIPRA Company Information
7.4.2 HIPRA Introduction and Business Overview
7.4.3 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.4.5 HIPRA Recent Development
7.5 Ceva Santé Animale
7.5.1 Ceva Santé Animale Company Information
7.5.2 Ceva Santé Animale Introduction and Business Overview
7.5.3 Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.5.5 Ceva Santé Animale Recent Development
7.6 Harbin Pharmaceutical Group
7.6.1 Harbin Pharmaceutical Group Company Information
7.6.2 Harbin Pharmaceutical Group Introduction and Business Overview
7.6.3 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.6.5 Harbin Pharmaceutical Group Recent Development
7.7 Qilu Animal Health Products
7.7.1 Qilu Animal Health Products Company Information
7.7.2 Qilu Animal Health Products Introduction and Business Overview
7.7.3 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.7.5 Qilu Animal Health Products Recent Development
7.8 Guangdong Winsun Bio-Pharmaceutical
7.8.1 Guangdong Winsun Bio-Pharmaceutical Company Information
7.8.2 Guangdong Winsun Bio-Pharmaceutical Introduction and Business Overview
7.8.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.8.5 Guangdong Winsun Bio-Pharmaceutical Recent Development
7.9 Jilin HeYuan Bioengineering
7.9.1 Jilin HeYuan Bioengineering Company Information
7.9.2 Jilin HeYuan Bioengineering Introduction and Business Overview
7.9.3 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.9.5 Jilin HeYuan Bioengineering Recent Development
7.10 Jofunhwa Biotechnology
7.10.1 Jofunhwa Biotechnology Company Information
7.10.2 Jofunhwa Biotechnology Introduction and Business Overview
7.10.3 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.10.5 Jofunhwa Biotechnology Recent Development
8 Industry Chain Analysis
8.1 Swine Mycoplasma Pneumonia Live Vaccine Industrial Chain
8.2 Swine Mycoplasma Pneumonia Live Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Swine Mycoplasma Pneumonia Live Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Swine Mycoplasma Pneumonia Live Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Swine Mycoplasma Pneumonia Live Vaccine Product Introduction
1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Market Size Forecast
1.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030)
1.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume (2019-2030)
1.2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Price (2019-2030)
1.3 Swine Mycoplasma Pneumonia Live Vaccine Market Trends & Drivers
1.3.1 Swine Mycoplasma Pneumonia Live Vaccine Industry Trends
1.3.2 Swine Mycoplasma Pneumonia Live Vaccine Market Drivers & Opportunity
1.3.3 Swine Mycoplasma Pneumonia Live Vaccine Market Challenges
1.3.4 Swine Mycoplasma Pneumonia Live Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Players Revenue Ranking (2023)
2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Company (2019-2024)
2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Players Sales Volume Ranking (2023)
2.4 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Swine Mycoplasma Pneumonia Live Vaccine
2.9 Swine Mycoplasma Pneumonia Live Vaccine Market Competitive Analysis
2.9.1 Swine Mycoplasma Pneumonia Live Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Swine Mycoplasma Pneumonia Live Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Mycoplasma Pneumonia Live Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 168 Strains
3.1.2 RM48 Strains
3.1.3 Other
3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type
3.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Type
3.3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Piglets
4.1.2 Adult Pigs
4.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application
4.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Application
4.3.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region
5.1.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region
5.2.1 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
5.4.2 North America Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
5.5.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
5.7.2 South America Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value
6.2.1 Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.3.2 United States Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.4.2 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.5.2 China Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.6.2 Japan Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.7.2 South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019-2030
6.9.2 India Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Company Information
7.1.2 Zoetis Introduction and Business Overview
7.1.3 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.1.5 Zoetis Recent Development
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Information
7.2.2 Boehringer Ingelheim Introduction and Business Overview
7.2.3 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.2.5 Boehringer Ingelheim Recent Development
7.3 Merck
7.3.1 Merck Company Information
7.3.2 Merck Introduction and Business Overview
7.3.3 Merck Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Merck Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.3.5 Merck Recent Development
7.4 HIPRA
7.4.1 HIPRA Company Information
7.4.2 HIPRA Introduction and Business Overview
7.4.3 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.4.5 HIPRA Recent Development
7.5 Ceva Santé Animale
7.5.1 Ceva Santé Animale Company Information
7.5.2 Ceva Santé Animale Introduction and Business Overview
7.5.3 Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.5.5 Ceva Santé Animale Recent Development
7.6 Harbin Pharmaceutical Group
7.6.1 Harbin Pharmaceutical Group Company Information
7.6.2 Harbin Pharmaceutical Group Introduction and Business Overview
7.6.3 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.6.5 Harbin Pharmaceutical Group Recent Development
7.7 Qilu Animal Health Products
7.7.1 Qilu Animal Health Products Company Information
7.7.2 Qilu Animal Health Products Introduction and Business Overview
7.7.3 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.7.5 Qilu Animal Health Products Recent Development
7.8 Guangdong Winsun Bio-Pharmaceutical
7.8.1 Guangdong Winsun Bio-Pharmaceutical Company Information
7.8.2 Guangdong Winsun Bio-Pharmaceutical Introduction and Business Overview
7.8.3 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.8.5 Guangdong Winsun Bio-Pharmaceutical Recent Development
7.9 Jilin HeYuan Bioengineering
7.9.1 Jilin HeYuan Bioengineering Company Information
7.9.2 Jilin HeYuan Bioengineering Introduction and Business Overview
7.9.3 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.9.5 Jilin HeYuan Bioengineering Recent Development
7.10 Jofunhwa Biotechnology
7.10.1 Jofunhwa Biotechnology Company Information
7.10.2 Jofunhwa Biotechnology Introduction and Business Overview
7.10.3 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
7.10.5 Jofunhwa Biotechnology Recent Development
8 Industry Chain Analysis
8.1 Swine Mycoplasma Pneumonia Live Vaccine Industrial Chain
8.2 Swine Mycoplasma Pneumonia Live Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Swine Mycoplasma Pneumonia Live Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Swine Mycoplasma Pneumonia Live Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Swine Mycoplasma Pneumonia Live Vaccine Market Trends
Table 2. Swine Mycoplasma Pneumonia Live Vaccine Market Drivers & Opportunity
Table 3. Swine Mycoplasma Pneumonia Live Vaccine Market Challenges
Table 4. Swine Mycoplasma Pneumonia Live Vaccine Market Restraints
Table 5. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Swine Mycoplasma Pneumonia Live Vaccine Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Swine Mycoplasma Pneumonia Live Vaccine
Table 13. Global Swine Mycoplasma Pneumonia Live Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Mycoplasma Pneumonia Live Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, (2025-2030) & (K Units)
Table 57. Zoetis Company Information
Table 58. Zoetis Introduction and Business Overview
Table 59. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 61. Zoetis Recent Development
Table 62. Boehringer Ingelheim Company Information
Table 63. Boehringer Ingelheim Introduction and Business Overview
Table 64. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 66. Boehringer Ingelheim Recent Development
Table 67. Merck Company Information
Table 68. Merck Introduction and Business Overview
Table 69. Merck Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Merck Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 71. Merck Recent Development
Table 72. HIPRA Company Information
Table 73. HIPRA Introduction and Business Overview
Table 74. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 76. HIPRA Recent Development
Table 77. Ceva Santé Animale Company Information
Table 78. Ceva Santé Animale Introduction and Business Overview
Table 79. Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 81. Ceva Santé Animale Recent Development
Table 82. Harbin Pharmaceutical Group Company Information
Table 83. Harbin Pharmaceutical Group Introduction and Business Overview
Table 84. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 86. Harbin Pharmaceutical Group Recent Development
Table 87. Qilu Animal Health Products Company Information
Table 88. Qilu Animal Health Products Introduction and Business Overview
Table 89. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 91. Qilu Animal Health Products Recent Development
Table 92. Guangdong Winsun Bio-Pharmaceutical Company Information
Table 93. Guangdong Winsun Bio-Pharmaceutical Introduction and Business Overview
Table 94. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 96. Guangdong Winsun Bio-Pharmaceutical Recent Development
Table 97. Jilin HeYuan Bioengineering Company Information
Table 98. Jilin HeYuan Bioengineering Introduction and Business Overview
Table 99. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 101. Jilin HeYuan Bioengineering Recent Development
Table 102. Jofunhwa Biotechnology Company Information
Table 103. Jofunhwa Biotechnology Introduction and Business Overview
Table 104. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 106. Jofunhwa Biotechnology Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Swine Mycoplasma Pneumonia Live Vaccine Downstream Customers
Table 110. Swine Mycoplasma Pneumonia Live Vaccine Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Mycoplasma Pneumonia Live Vaccine Product Picture
Figure 2. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Price (2019-2030) & (US$/Unit)
Figure 6. Swine Mycoplasma Pneumonia Live Vaccine Report Years Considered
Figure 7. Global Swine Mycoplasma Pneumonia Live Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Swine Mycoplasma Pneumonia Live Vaccine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Mycoplasma Pneumonia Live Vaccine Revenue in 2023
Figure 10. Swine Mycoplasma Pneumonia Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. 168 Strains Picture
Figure 12. RM48 Strains Picture
Figure 13. Other Picture
Figure 14. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Piglets
Figure 20. Product Picture of Adult Pigs
Figure 21. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Volume (%), (2019-2030)
Figure 38. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 44. China Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 46. China Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 56. India Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 58. India Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 59. Swine Mycoplasma Pneumonia Live Vaccine Industrial Chain
Figure 60. Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Swine Mycoplasma Pneumonia Live Vaccine Market Trends
Table 2. Swine Mycoplasma Pneumonia Live Vaccine Market Drivers & Opportunity
Table 3. Swine Mycoplasma Pneumonia Live Vaccine Market Challenges
Table 4. Swine Mycoplasma Pneumonia Live Vaccine Market Restraints
Table 5. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Swine Mycoplasma Pneumonia Live Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Swine Mycoplasma Pneumonia Live Vaccine Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Swine Mycoplasma Pneumonia Live Vaccine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Swine Mycoplasma Pneumonia Live Vaccine
Table 13. Global Swine Mycoplasma Pneumonia Live Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Mycoplasma Pneumonia Live Vaccine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (2019-2024) & (%)
Table 44. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Region (2025-2030) & (%)
Table 45. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Swine Mycoplasma Pneumonia Live Vaccine Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Volume, (2025-2030) & (K Units)
Table 57. Zoetis Company Information
Table 58. Zoetis Introduction and Business Overview
Table 59. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Zoetis Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 61. Zoetis Recent Development
Table 62. Boehringer Ingelheim Company Information
Table 63. Boehringer Ingelheim Introduction and Business Overview
Table 64. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Boehringer Ingelheim Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 66. Boehringer Ingelheim Recent Development
Table 67. Merck Company Information
Table 68. Merck Introduction and Business Overview
Table 69. Merck Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Merck Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 71. Merck Recent Development
Table 72. HIPRA Company Information
Table 73. HIPRA Introduction and Business Overview
Table 74. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. HIPRA Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 76. HIPRA Recent Development
Table 77. Ceva Santé Animale Company Information
Table 78. Ceva Santé Animale Introduction and Business Overview
Table 79. Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Ceva Santé Animale Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 81. Ceva Santé Animale Recent Development
Table 82. Harbin Pharmaceutical Group Company Information
Table 83. Harbin Pharmaceutical Group Introduction and Business Overview
Table 84. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Harbin Pharmaceutical Group Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 86. Harbin Pharmaceutical Group Recent Development
Table 87. Qilu Animal Health Products Company Information
Table 88. Qilu Animal Health Products Introduction and Business Overview
Table 89. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Qilu Animal Health Products Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 91. Qilu Animal Health Products Recent Development
Table 92. Guangdong Winsun Bio-Pharmaceutical Company Information
Table 93. Guangdong Winsun Bio-Pharmaceutical Introduction and Business Overview
Table 94. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Guangdong Winsun Bio-Pharmaceutical Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 96. Guangdong Winsun Bio-Pharmaceutical Recent Development
Table 97. Jilin HeYuan Bioengineering Company Information
Table 98. Jilin HeYuan Bioengineering Introduction and Business Overview
Table 99. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Jilin HeYuan Bioengineering Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 101. Jilin HeYuan Bioengineering Recent Development
Table 102. Jofunhwa Biotechnology Company Information
Table 103. Jofunhwa Biotechnology Introduction and Business Overview
Table 104. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Jofunhwa Biotechnology Swine Mycoplasma Pneumonia Live Vaccine Product Offerings
Table 106. Jofunhwa Biotechnology Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Swine Mycoplasma Pneumonia Live Vaccine Downstream Customers
Table 110. Swine Mycoplasma Pneumonia Live Vaccine Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Mycoplasma Pneumonia Live Vaccine Product Picture
Figure 2. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Price (2019-2030) & (US$/Unit)
Figure 6. Swine Mycoplasma Pneumonia Live Vaccine Report Years Considered
Figure 7. Global Swine Mycoplasma Pneumonia Live Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Swine Mycoplasma Pneumonia Live Vaccine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Mycoplasma Pneumonia Live Vaccine Revenue in 2023
Figure 10. Swine Mycoplasma Pneumonia Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. 168 Strains Picture
Figure 12. RM48 Strains Picture
Figure 13. Other Picture
Figure 14. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Piglets
Figure 20. Product Picture of Adult Pigs
Figure 21. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Swine Mycoplasma Pneumonia Live Vaccine Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Swine Mycoplasma Pneumonia Live Vaccine Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Swine Mycoplasma Pneumonia Live Vaccine Sales Volume (%), (2019-2030)
Figure 38. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 44. China Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 46. China Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 56. India Swine Mycoplasma Pneumonia Live Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 58. India Swine Mycoplasma Pneumonia Live Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 59. Swine Mycoplasma Pneumonia Live Vaccine Industrial Chain
Figure 60. Swine Mycoplasma Pneumonia Live Vaccine Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232